Filing Details

Accession Number:
0000885590-12-000029
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-14 18:57:28
Reporting Period:
2012-05-14
Filing Date:
2012-05-14
Accepted Time:
2012-05-14 17:57:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190966 E Laurence Paul 4787 Levy Street
Montreal A8 H4R 2P9
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2012-05-14 2,100 $51.03 34,497 No 4 P Direct
Common Stock, No Par Value Acquisiton 2012-05-14 2,900 $51.03 37,397 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1.